Petra H. Van Der Kraak

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Efficiency and immunogenicity of lipid nanoparticle-mediated cardiac mRNA delivery are lipid composition-dependent.

Efficiency and immunogenicity of lipid nanoparticle-mediated cardiac mRNA delivery are lipid composition-dependent.

Journal: Molecular therapy. Nucleic acids

Published: December 04, 2025

Candidate Biomarkers YES1, Troponin I, Lactate, and Ammonia for Evaluation of Cardiac Function Post Hypothermic Oxygenated Perfusion.

Candidate Biomarkers YES1, Troponin I, Lactate, and Ammonia for Evaluation of Cardiac Function Post Hypothermic Oxygenated Perfusion.

Journal: ASAIO journal (American Society for Artificial Internal Organs : 1992)

Published: March 25, 2025

Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept study.

Dexrazoxane protects against doxorubicin-induced cardiotoxicity in susceptible human living myocardial slices: A proof-of-concept study.

Journal: British journal of pharmacology

Published: December 13, 2024

EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathy.

EPAS1 induction drives myocardial degeneration in desmoplakin-cardiomyopathy.

Journal: iScience

Published: August 22, 2024

Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.

Inhibition of Hmbox1 Promotes Cardiomyocyte Survival and Glucose Metabolism Through Gck Activation in Ischemia/Reperfusion Injury.

Journal: Circulation

Published: May 06, 2024

Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix composition.

Cardiomyocyte SORBS2 expression increases in heart failure and regulates integrin interactions and extracellular matrix composition.

Journal: Cardiovascular research

Published: April 25, 2024

Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.

Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.

Journal: Science translational medicine

Published: March 22, 2023

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB-C/EBPβ Axis.

HIPK1 Inhibition Protects against Pathological Cardiac Hypertrophy by Inhibiting the CREB-C/EBPβ Axis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 27, 2023

PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathy.

PITX2 induction leads to impaired cardiomyocyte function in arrhythmogenic cardiomyopathy.

Journal: Stem cell reports

Published: August 29, 2022

Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.

Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy.

Journal: Cardiovascular research

Published: July 06, 2021

Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy.

Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy.

Journal: Cell reports

Published: January 05, 2021

Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation.

Impairment of the ER/mitochondria compartment in human cardiomyocytes with PLN p.Arg14del mutation.

Journal: EMBO molecular medicine

Published: July 07, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026